- $550.60m
- $1.40bn
- $1.88bn
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows
Evolent Health Q4 revenue slightly misses analyst expectations
Brief: Evolent Health Q4 Revenue USD 468.719 Million Vs. IBES Estimate USD 468.8 Million
U.S. RESEARCH ROUNDUP-Ardelyx, RPM International, Trubridge
Brief: Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08
U.S. RESEARCH ROUNDUP- Blackline, Carmax, Expedia
Brief: Evolent Health Inc - Appoints Mario Ramos As CFO Effective Jan 1, 2026 - SEC Filing
Evolent Health Q3 revenue beats expectations
Brief: Evolent Health Q3 Revenue USD 479.533 Million Vs. IBES Estimate USD 467.5 Million
Australia's Vitasora Health soars on extending deal with Evolent Care Partners
Brief: Privia Health Expands Value-Based Care Footprint With Acquisition Of Accountable Care Organization Business From Evolent Health
Brief: Evolent Announces Strategic Divestiture Of Its Value-Based Primary Care Business, Evolent Care Partners
U.S. STOCKS ON THE MOVE-Medtronic, NorthWestern Energy, GM
U.S. STOCKS ON THE MOVE-General Motors, Caterpillar, Medtronic
Evolent Health edges down after $145 mln convertible debt offering
Brief: Evolent Health Announces Pricing Of Oversubscribed And Upsized $145.0 Million Of Convertible Senior Notes Due 2031 To Repurchase Existing Notes And Class A Common Stock